It is associated with favorable prognoses in many cancers, while its antisense long, noncoding RNA (lncRNA), PITPNA-AS1, is overexpressed in gastric cancer tissues and associated with poor survival rates in gastric cancer patients [33]. This evidence concerns the gene PITPNA and cancer.